Nev Black Posted April 29, 2020 Share Posted April 29, 2020 Agenda for the July 2020 PBAC meeting 29 April 2020 The agenda for the July 2020 PBAC meeting is now available. Your comments are welcome whether you are a patient, carer, member of the public, health professional or member of a consumer interest group. The company applying for subsidy under the Pharmaceutical Benefits Scheme has already provided the PBAC with detailed clinical and economic data in support of the application. You are welcome to provide comments, for consideration by the PBAC, from a personal or group perspective on the impact of the condition addressed in the application. The Consumer Comments Submission form and further information can be found on the PBS website. Kind regards,PBS Publications teamPharmaceutical Benefits SchemeDepartment of Healthwww.pbs.gov.au New listing(Major Submission) DAROLUTAMIDETablet 300 mgNubeqa®Bayer Australia Pty Ltd Prostate cancer To request an Authority Required listing for the treatment of non-metastatic castration-resistant prostate cancer. Link to comment Share on other sites More sharing options...
Recommended Posts